Advertisement

Molecular Biology Reports

, Volume 38, Issue 4, pp 2491–2497 | Cite as

Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies

  • RongGui Zhang
  • GuangYong Xu
  • WenJun Chen
  • WeiLi Zhang
Article

Abstract

Studies investigating the association between glutathione S-transferase M1 (GSTM1) polymorphism and bladder cancer risk report conflicting results. The objective of this study was to quantitatively summarize the evidence for such a relationship. We performed a systematic search of the National Library of Medline and Embase databases. This meta-analysis included 26 case-control studies, which included 5029 bladder cancer cases and 6680 controls. The combined results based on all studies showed that the GSTM1 null genotype was associated with an increased risk of bladder cancer (OR = 1.46, 95% confidence interval [CI] = 1.35, 1.57). When stratifying for race, results were similar among Asians (OR = 1.60, 95% CI = 1.27, 2.01) and Caucasians (OR = 1.44, 95% CI = 1.33, 1.57) except Africans (OR = 1.25, 95% CI = 0.76, 2.06). When stratifying by the smoking, stage, grade, and histological type of bladder cancer, we found no statistical association. Our meta-analysis suggests that the GSTM1 null genotype is associated with a modest increase in the risk of bladder cancer.

Keywords

Bladder cancer Glutathione S-transferase M1 Gene polymorphism Meta-analysis 

Notes

Acknowledgments

We thank Dr. Yanjun Lin (Department of Urology, the Second Affiliated Hospital, Chongqing Medical University) for the assistance of data collection and preparation of the manuscript.

Conflict of interest

None.

References

  1. 1.
    Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96PubMedCrossRefGoogle Scholar
  2. 2.
    Zeegers MP, Tan FE, Dorant E et al (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89:630–639PubMedCrossRefGoogle Scholar
  3. 3.
    Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239–249PubMedCrossRefGoogle Scholar
  4. 4.
    Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis. Clin Exp Med 10:59–68PubMedCrossRefGoogle Scholar
  5. 5.
    Kellen E, Hemelt M, Broberg K et al (2007) Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 165:1221–1230PubMedCrossRefGoogle Scholar
  6. 6.
    Thakur MK, Ghosh S (2010) GST-tagged mouse estrogen receptor alpha-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification. Mol Biol Rep 37:1335–1340PubMedCrossRefGoogle Scholar
  7. 7.
    Liu D, Liao M, Zuo J et al (2001) The effect of chemical carcinogenesis on rat glutathione S-transferase P1 gene transcriptional regulation. Mol Biol Rep 28:19–25PubMedCrossRefGoogle Scholar
  8. 8.
    Zendeh-Boodi Z, Saadat M (2008) Genetic polymorphism of GSTT1 may be under natural selection in a population chronically exposed to natural sour gas. Mol Biol Rep 35:673–676PubMedCrossRefGoogle Scholar
  9. 9.
    Saadat M (2009) Serum levels of testosterone and gonadotrophins with respect to smoking status and genetic polymorphism of GSTT1. Mol Biol Rep 36:1353–1356PubMedCrossRefGoogle Scholar
  10. 10.
    Tang JJ, Wang MW, Jia EZ et al (2010) The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study. Mol Biol Rep 37:405–410PubMedCrossRefGoogle Scholar
  11. 11.
    Azarpira N, Nikeghbalian S, Geramizadeh B et al (2010) Influence of glutathione S-transferase M1 and T1 polymorphisms with acute rejection in Iranian liver transplant recipients. Mol Biol Rep 37:21–25PubMedCrossRefGoogle Scholar
  12. 12.
    Rafiee L, Saadat I, Saadat M (2010) Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 37:155–158PubMedCrossRefGoogle Scholar
  13. 13.
    Saadat I, Saadat M (2010) Influence of genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) on hematological parameters. Mol Biol Rep 37:249–253PubMedCrossRefGoogle Scholar
  14. 14.
    Masoudi M, Saadat I, Omidvari S et al (2009) Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 36:781–784PubMedCrossRefGoogle Scholar
  15. 15.
    Ye Z, Parry JM (2003) A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 9:SR83–SR91PubMedGoogle Scholar
  16. 16.
    Altinisik J, Balta ZB, Aydin G et al (2010) Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer. Mol Biol Rep 37:263–267PubMedCrossRefGoogle Scholar
  17. 17.
    Sull JW, Ohrr H, Kang DR et al (2004) Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med J 45:683–689PubMedGoogle Scholar
  18. 18.
    Tripathy CB, Roy N (2006) Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 28:217–224PubMedCrossRefGoogle Scholar
  19. 19.
    Engel LS, Taioli E, Pfeiffer R et al (2002) Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156:95–109PubMedCrossRefGoogle Scholar
  20. 20.
    Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedGoogle Scholar
  21. 21.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRefGoogle Scholar
  22. 22.
    Harries LW, Stubbins MJ, Forman D et al (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641–644PubMedCrossRefGoogle Scholar
  23. 23.
    Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729–734PubMedCrossRefGoogle Scholar
  24. 24.
    Cao W, Cai L, Rao JY et al (2005) Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104:2400–2408PubMedCrossRefGoogle Scholar
  25. 25.
    Mittal RD, Srivastava DS AM et al (2005) Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev 6:6–9PubMedGoogle Scholar
  26. 26.
    Kopps S, Angeli-Greaves M, Blaszkewicz M et al (2008) Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases. J Toxicol Environ Health A 71:898–901PubMedCrossRefGoogle Scholar
  27. 27.
    Okkels H, Sigsgaard T, Wolf H et al (1997) Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev 6:225–231PubMedGoogle Scholar
  28. 28.
    Martone T, Vineis P, Malaveille C et al (2000) Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer. Mutat Res 462:303–309PubMedCrossRefGoogle Scholar
  29. 29.
    Kellen E, Zeegers M, Paulussen A et al (2007) Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk. Cancer Lett 245:51–60PubMedCrossRefGoogle Scholar
  30. 30.
    Rioja Zuazu J, Bandres Elizalde E, Rosell Costa D et al (2007) Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors. Actas Urol Esp 31:1107–1116PubMedCrossRefGoogle Scholar
  31. 31.
    Srivastava DS, Kumar A, Mittal B et al (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430–434PubMedCrossRefGoogle Scholar
  32. 32.
    Abd El Hameed AH, Negm OE, El-Gamal OM et al (2008) Genetic polymorphism of glutathione S-transferases M1 and T1 in Egyptian patients with bilharzial bladder cancer. Urol Oncol: doi: 10.1016/j.urolonc.2008.1009.1015
  33. 33.
    Zhong S, Wyllie AH, Barnes D et al (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821–1824PubMedCrossRefGoogle Scholar
  34. 34.
    Anwar WA, Abdel-Rahman SZ, El-Zein RA et al (1996) Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17:1923–1929PubMedCrossRefGoogle Scholar
  35. 35.
    Brockmoller J, Cascorbi I, Kerb R et al (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915–3925PubMedGoogle Scholar
  36. 36.
    Kim WJ, Lee HL, Lee SC et al (2000) Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 164:209–213PubMedCrossRefGoogle Scholar
  37. 37.
    Aktas D, Ozen H, Atsu N et al (2001) Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. A marker for invasive bladder cancer? Cancer Genet Cytogenet 125:1–4PubMedCrossRefGoogle Scholar
  38. 38.
    Toruner GA, Akyerli C, Ucar A et al (2001) Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75:459–464PubMedCrossRefGoogle Scholar
  39. 39.
    Ma QW, Lin GF, Chen JG et al (2002) Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed Environ Sci 15:253–260PubMedGoogle Scholar
  40. 40.
    Jong Jeong H, Jin Kim H, Young Seo I et al (2003) Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett 202:193–199PubMedCrossRefGoogle Scholar
  41. 41.
    Hung RJ, Boffetta P, Brennan P et al (2004) GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110:598–604PubMedCrossRefGoogle Scholar
  42. 42.
    Moore LE, Wiencke JK, Bates MN et al (2004) Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211:199–207PubMedCrossRefGoogle Scholar
  43. 43.
    Saad AA, O’Connor PJ, Mostafa MH et al (2005) Glutathione S-transferase M1, T1 and P1 polymorphisms and bladder cancer risk in Egyptians. Int J Biol Markers 20:69–72PubMedGoogle Scholar
  44. 44.
    Sobti RC, Al-Badran AI, Sharma S et al (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68–73PubMedCrossRefGoogle Scholar
  45. 45.
    Srivastava DS, Mishra DK, Mandhani A et al (2005) Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48:339–344PubMedCrossRefGoogle Scholar
  46. 46.
    McGrath M, Michaud D, De Vivo I (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 6:239PubMedCrossRefGoogle Scholar
  47. 47.
    Cengiz M, Ozaydin A, Ozkilic AC et al (2007) The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol 39:1043–1048PubMedCrossRefGoogle Scholar
  48. 48.
    Moore LE, Malats N, Rothman N et al (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120:2452–2458PubMedCrossRefGoogle Scholar
  49. 49.
    Murta-Nascimento C, Silverman DT, Kogevinas M et al (2007) Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 16:1595–1600PubMedCrossRefGoogle Scholar
  50. 50.
    Zhao H, Lin J, Grossman HB et al (2007) Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer 120:2208–2213PubMedCrossRefGoogle Scholar
  51. 51.
    Covolo L, Placidi D, Gelatti U et al (2008) Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol 23:355–362PubMedCrossRefGoogle Scholar
  52. 52.
    Altayli E, Gunes S, Yilmaz AF et al (2009) CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol 41:259–266PubMedCrossRefGoogle Scholar
  53. 53.
    Grando JP, Kuasne H, Losi-Guembarovski R et al (2009) Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med 9:21–28PubMedCrossRefGoogle Scholar
  54. 54.
    Rouissi K, Ouerhani S, Marrakchi R et al (2009) Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet 190:101–107PubMedCrossRefGoogle Scholar
  55. 55.
    Song DK, Xing DL, Zhang LR et al (2009) Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev 32:416–423PubMedCrossRefGoogle Scholar
  56. 56.
    Zupa A, Sgambato A, Bianchino G et al (2009) GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. Anticancer Res 29:1709–1714PubMedGoogle Scholar
  57. 57.
    Ioannidis JP, Boffetta P, Little J et al (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37:120–132PubMedCrossRefGoogle Scholar
  58. 58.
    Carlsten C, Sagoo GS, Frodsham AJ et al (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759–774PubMedCrossRefGoogle Scholar
  59. 59.
    La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217:53–60PubMedCrossRefGoogle Scholar
  60. 60.
    Karagas MR, Park S, Warren A et al (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63–69PubMedCrossRefGoogle Scholar
  61. 61.
    Cantor KP, Lynch CF, Hildesheim ME et al (1998) Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology 9:21–28PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • RongGui Zhang
    • 1
  • GuangYong Xu
    • 1
  • WenJun Chen
    • 1
  • WeiLi Zhang
    • 1
  1. 1.Department of Urology, The Second Affiliated HospitalChongqing Medical UniversityChongqingChina

Personalised recommendations